Dr. Bredesen first published research results which showed significant improvement in 90% of respondents.

Dr Bredesen was recently interviewed by CBN news where he discussed in depth his research into the cognitive decline of the brain and how the use of natural minerals can help not only stop but reverse some stages of Alzheimer’s.

Watch the complete interview below on the CBN News site below:

Doctor Finds Natural Ways to Reverse and Prevent Alzheimer's

Dr. Dale Bredesen has spent 30 years studying what causes Alzheimer's Disease and how to treat it. He says it's no longer a mystery illness - we know why you get it and we know what to do about it and how to prevent it.

Can you reverse the symptoms of Alzheimer’s?

Just the word, “Alzheimer’s” can be frightening. It steals memories and is one of America’s leading causes of death. But Dr. Dale Bredesen, author of the book, The End of Alzheimer’s, has researched Alzheimer’s for decades. He says it’s possible to not only prevent its onset, but actually reverse the symptoms of the disease.

Dr. Dale Bredesen has spent over 30 years researching the treatment and prevention of Alzheimer’s disease and has recently published the first paper on the Reversal Of Cognitive Decline in patients with early Alzheimer’s disease and its precursors, MCI and SCI. He was also interviewed by Integrative Medicine in October 2015 regarding this pioneering research.

Initially, Dr. Bredesen first published his research results in peer-reviewed medical journals such as Aging, in which he showed significant improvement in 90% of respondents.

“Alzheimer’s disease is no longer a mystery,” he explains, “You don’t have to say, ‘We don’t know why you get it. We don’t know what to do about it. We do know why you get it. We do know what to do about it. And we know how to prevent it.”

CogMission, Embracing The Bredesen Protocolâ„¢

Based in Edinburgh, Scotland, CogMission use the Bredesen Protocol to develop a comprehensive and personalised program to improve cognition and reverse the cognitive decline of SCI, MCI, and early Alzheimer’s disease.